Literature DB >> 17553462

E-LDL upregulates TOSO expression and enhances the survival of human macrophages.

Alexander Sigruener1, Christa Buechler, Salim Maa Bared, Margot Grandl, Charalampos Aslanidis, Peter Ugocsai, Mathias Gehrmann, Gerd Schmitz.   

Abstract

Uptake of modified lipoproteins by macrophages causes foam cell formation and promotes atherosclerosis. Atherogenic lipoproteins are cytotoxic and induce cell death under certain conditions but may also enhance macrophage survival. Macrophages treated with enzymatically modified LDL (E-LDL) were subjected to GeneChip analysis and the antiapoptotic gene TOSO was found induced. TOSO mRNA is upregulated and apoptosis is reduced in E-LDL but not in oxidized LDL (Ox-LDL) loaded macrophages. FLIP(L) abundance was suggested to mediate the antiapoptotic properties of TOSO; however, FLIP(L) was not changed. Ox-LDL is internalized predominantly by scavenger receptors such as CD36 while E-LDL particles are preferentially internalized by Fc- and complement-receptor dependent phagocytosis and internalization of phagobeads by macrophages upregulates TOSO. In COS-7 cells however, phagocytotic activity was not affected by TOSO. These data indicate that E-LDL-generated foam cells are protected from cell death most likely through the expression of TOSO by a FLIP(L) independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553462     DOI: 10.1016/j.bbrc.2007.05.169

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Reply to Honjo et al.: Functional relevant expression of Toso on granulocytes.

Authors:  Karl S Lang; Philipp A Lang; Andreas Meryk; Aleksandra A Pandyra; Katja Merches; Kyeong-Hee Lee; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

2.  Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection.

Authors:  P A Lang; A Meryk; A A Pandyra; D Brenner; A Brüstle; H C Xu; K Merches; F Lang; V Khairnar; P Sharma; P Funkner; M Recher; N Shaabani; G S Duncan; V Duhan; B Homey; P S Ohashi; D Häussinger; P A Knolle; N Honke; T W Mak; K S Lang
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

3.  Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.

Authors:  Dirk Brenner; Anne Brüstle; Gloria H Y Lin; Philipp A Lang; Gordon S Duncan; Christiane B Knobbe-Thomsen; Michael St Paul; Colin Reardon; Michael W Tusche; Bryan Snow; Sara R Hamilton; Aline Pfefferle; Syed O Gilani; Pamela S Ohashi; Karl S Lang; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-07       Impact factor: 11.205

4.  Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.

Authors:  Veysel Sabri Hancer; Reyhan Diz-Kucukkaya; Melih Aktan
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

5.  TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.

Authors:  Bérengère Vire; Alexandre David; Adrian Wiestner
Journal:  J Immunol       Date:  2011-09-09       Impact factor: 5.422

6.  Analytical workflow profiling gene expression in murine macrophages.

Authors:  Scott E Nixon; Dianelys González-Peña; Marcus A Lawson; Robert H McCusker; Alvaro G Hernandez; Jason C O'Connor; Robert Dantzer; Keith W Kelley; Sandra L Rodriguez-Zas
Journal:  J Bioinform Comput Biol       Date:  2015-01-14       Impact factor: 1.122

7.  Reply to: Questioning whether the IgM Fc receptor (FcμR) is expressed by innate immune cells.

Authors:  Shawn P Kubli; Parameswaran Ramachandran; Gordon Duncan; Rich Brokx; Tak W Mak
Journal:  Nat Commun       Date:  2022-07-11       Impact factor: 17.694

8.  Involvement of Toso in activation of monocytes, macrophages, and granulocytes.

Authors:  Karl S Lang; Philipp A Lang; Andreas Meryk; Aleksandra A Pandyra; Louis-Martin Boucher; Vitaly I Pozdeev; Michael W Tusche; Joachim R Göthert; Jillian Haight; Andrew Wakeham; Annick J You-Ten; David R McIlwain; Katja Merches; Vishal Khairnar; Mike Recher; Garry P Nolan; Yasumichi Hitoshi; Pauline Funkner; Alexander A Navarini; Admar Verschoor; Namir Shaabani; Nadine Honke; Linda Z Penn; Pamela S Ohashi; Dieter Häussinger; Kyeong-Hee Lee; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

9.  IgM in human immunity to Plasmodium falciparum malaria.

Authors:  M J Boyle; J A Chan; I Handayuni; L Reiling; G Feng; A Hilton; L Kurtovic; D Oyong; K A Piera; B E Barber; T William; D P Eisen; G Minigo; C Langer; D R Drew; F de Labastida Rivera; F H Amante; T N Williams; S Kinyanjui; K Marsh; D L Doolan; C Engwerda; F J I Fowkes; M J Grigg; I Mueller; J S McCarthy; N M Anstey; J G Beeson
Journal:  Sci Adv       Date:  2019-09-25       Impact factor: 14.136

10.  Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.

Authors:  Stefan Wallner; Evelyn Orsó; Margot Grandl; Tatiana Konovalova; Gerhard Liebisch; Gerd Schmitz
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.